Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Buloxibutid | 477775-14-7 | MFCD26936332 | 475.62 | C23H29N3O4S2 | 25 MG
SDP

Catalog No. 5000214982
Encompass_Preferred

Buloxibutid is a selective angiotensin II type 2 (AT2) receptor agonist (C21) used in research to probe AT2-mediated signaling. It exhibits high affinity for the AT2 receptor (Ki = 0.4 nM) and markedly lower affinity for the AT1 receptor (Ki > 10 μM), supporting its use as a tool compound for AT2-specific pharmacology.

  • Selective angiotensin II type 2 (AT2) receptor agonist
  • High AT2 affinity (Ki = 0.4 nM)
  • Minimal AT1 activity (Ki > 10 μM)
  • Chemical formula C23H29N3O4S2; molecular weight 475.62
  • Soluble in DMSO (50 mg/mL); in vivo formulations documented
  • Storage: powder -20°C; in solvent -80°C for 6 months or -20°C for 1 month

Catalog No. 50-002-14982 Supplier Medchemexpress LLC Supplier No. HY10011325MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Buloxibutid is a selective angiotensin II type 2 (AT2) receptor agonist (C21) used in research to probe AT2-mediated signaling. It exhibits high affinity for the AT2 receptor (Ki = 0.4 nM) and markedly lower affinity for the AT1 receptor (Ki > 10 μM), supporting its use as a tool compound for AT2-specific pharmacology.

  • Selective angiotensin II type 2 (AT2) receptor agonist
  • High AT2 affinity (Ki = 0.4 nM)
  • Minimal AT1 activity (Ki > 10 μM)
  • Chemical formula C23H29N3O4S2; molecular weight 475.62
  • Soluble in DMSO (50 mg/mL); in vivo formulations documented
  • Storage: powder -20°C; in solvent -80°C for 6 months or -20°C for 1 month

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.